Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Regular ✕Edelweiss Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundEdelweiss Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseHDFCEdelweiss
NAV₹22.8170₹9.2021
NAV date20 Nov 202620 Nov 2026
History3.1 years2.3 years
Expense ratio2.1%2.7%
Stars★★★★★Not rated
Growth Score93.90—

Returns

HDFC Pharma and Healthcare FundEdelweiss Business Cycle Fund
1 month+12.87%+5.71%
3 months+6.85%+0.80%
6 months+17.20%+4.95%
YTD+32.43%+1.69%
1 year+30.73%+2.20%
3 years (CAGR)+29.16%—
5 years (CAGR)——
10 years (CAGR)——
Since launch+30.28%−3.74%

Risk

HDFC Pharma and Healthcare FundEdelweiss Business Cycle Fund
Volatility15.8%—
Downside volatility8.6%—
Sharpe1.44—
Sortino2.64—
Calmar1.94—
Return / risk1.85—
Deepest fall−15.07%−26.91%
Days to recover133—
Below its high+0.00%−10.68%

Against benchmark

HDFC Pharma and Healthcare FundEdelweiss Business Cycle Fund
Alpha+6.36%—
Beta0.97—
R²85.0%—
Up capture106.7%—
Down capture74.4%—
Tracking error6.1%—
Information ratio0.97—
Treynor0.22—

Consistency

HDFC Pharma and Healthcare FundEdelweiss Business Cycle Fund
Best 1-year+64.96%+19.06%
Middle 1-year+21.84%−0.57%
Worst 1-year+0.52%−16.02%
1-year periods with a loss0.0%51.7%
Middle 3-year+28.68%—
Positive months69.4%—
Best day+3.19%+4.77%
Worst day−3.62%−3.86%
Worst 5% day−1.50%−2.02%
Positive days58.1%53.1%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundEdelweiss Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+26.26%—
1-year XIRR+39.84%+7.48%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth